GlassScriptPhysician profile
Robert T Bagwell
NPI 1518303510
$20,010.33
in general payments reported to CMS, 2019-2025
36 companies · $4,293 in 2025
The $4,293 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $474 · 2020: $1,102 · 2021: $3,888 · 2022: $4,809 · 2023: $2,497 · 2024: $2,948 · 2025: $4,293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,066 · Travel and Lodging: $2,672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,066.17 |
| Travel and Lodging | $2,671.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,833.90 | 2019-2025 | Perclose Proglide, Supera, Dragonfly Opstar |
| Edwards Lifesciences Corporation | $2,452.61 | 2021-2025 | Pascal |
| Abiomed | $2,242.48 | 2020-2025 | |
| Penumbra, INC. | $1,919.20 | 2020-2024 | Indigo System |
| Medtronic, INC. | $1,140.30 | 2021-2025 | Venaseal, Harmony, Corevalve Evolut R |
| Boston Scientific Corporation | $1,120.50 | 2020-2025 | General - Balloon Catheters, Ekosonic, Eluvia |
| W. L. Gore & Associates, INC. | $693.12 | 2021-2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $645.07 | 2020-2025 | Lifevest |
| Cardiovascular Systems INC. | $513.51 | 2020-2022 | |
| Astellas Pharma US INC | $501.56 | 2019-2021 | |
| Angiodynamics, INC. | $467.00 | 2022-2025 | Alphavac |
| Actelion Pharmaceuticals US, INC. | $346.73 | 2021-2024 | Opsumit, Uptravi |
| Cook Medical LLC | $265.76 | 2025 | Zilver Ptx |
| Terumo Medical Corporation | $237.37 | 2022-2024 | Metacross Otw, Angio-Seal, Tr Band |
| Amgen INC. | $213.85 | 2019-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $208.01 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $192.15 | 2020-2025 | |
| Pfizer INC. | $190.38 | 2019-2024 | |
| Bard Peripheral Vascular, INC. | $171.65 | 2022-2023 | Crosser Iq, Halo One Thin-Walled Guiding Sheath |
| Impulse Dynamics (USA) INC. | $169.27 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $152.21 | 2019-2022 | |
| Inari Medical, INC. | $147.81 | 2021 | |
| Becton, Dickinson and Company | $145.73 | 2022 | |
| Avinger INC. | $142.98 | 2023 | Pantheris |
| Surmodics, INC. | $133.79 | 2023 | Pounce Venous Thrombectomy System, Pounce Thrombectomy System, Pounce Thrombectomy |
| Cagent Vascular INC | $131.76 | 2023 | Serrantor |
| Endologix LLC | $123.92 | 2025 | Endocross Device, Torus Stent Graft System |
| Chiesi USA, INC. | $114.57 | 2020-2022 | |
| Novo Nordisk INC | $105.21 | 2022 | |
| Saranas, INC. | $88.24 | 2021 | |
| Sanofi-Aventis U.S. LLC | $59.71 | 2022 | |
| Cardinal Health 200 LLC | $50.99 | 2020-2021 | |
| Cardiva Medical, INC. | $35.54 | 2022 | |
| Philips North America LLC | $25.78 | 2019 | |
| Portola Pharmaceuticals, LLC | $15.79 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bagwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.